Industrials·Building Products·$6.2B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.58 | N/A | +24.73% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.58 | N/A | +24.73% |
| Revenue | N/A | N/A | N/A |
Tone: Neutral
Management expressed satisfaction with the EPS results but did not provide specific revenue figures. They remain focused on operational improvements.
Management highlighted strong performance in the EPS despite the lack of revenue details.
They emphasized ongoing efforts to improve operational efficiency.
Resideo Technologies reported a strong EPS performance, exceeding expectations by nearly 25%. However, the stock reacted negatively, declining by 0.68%. The lack of revenue details and forward guidance may have contributed to investor caution.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VERTEX PHARMACEUTICA
Nov 4, 2024